OQROGet OQRO Pro
Insider trade

Twist Bioscience (TWST)Director sold ~$250K

Robert Chess, Director at Twist Bioscience, sold ~$250K of Twist Bioscience shares.

~$250K
Approx. value · 5,000 sh @ $50.00
17K
Holds after · shares reported
Traded
Jan 7, 2025
Filed
Jan 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 6, 2024Insider · 6 peopleInsiders: 6 sales (~$1.5M)
  2. Nov 11, 2024Insider · 5 peopleInsiders: 6 sales (~$1.2M)
  3. Nov 25, 2024InsiderOfficer sold ~$35K of TWST shares in the open market
  4. Dec 5, 2024Insider · 1 personInsiders: 2 sales (~$182K)
  5. Dec 6, 2024Insider · 4 peopleInsiders: 4 sales (~$193K)
  6. Dec 16, 2024InsiderOfficer sold ~$6.2K of TWST shares in the open market
  7. Dec 20, 2024Insider · 3 peopleInsiders: 3 sales (~$101K)
  8. Jan 3, 2025Insider · 4 peopleInsiders: 4 sales (~$49K)
  9. Jan 7, 2025 · this disclosureInsiderDirector sold ~$250K of TWST shares in the open market

What came next

  1. Jan 10, 2025InsiderCFO sold ~$255K of TWST shares in the open market
  2. Jan 23, 2025InsiderOfficer sold ~$122K of TWST shares in the open market
  3. Feb 3, 2025Insider · 5 peopleInsiders: 5 sales (~$508K)
  4. Feb 7, 2025InsiderDirector sold ~$156K of TWST shares in the open market
  5. Feb 21, 2025Insider · 6 peopleInsiders: 6 sales (~$307K)
  6. Feb 24, 2025InsiderOfficer sold ~$38K of TWST shares in the open market
  7. Mar 6, 2025Insider · 4 peopleInsiders: 4 sales (~$157K)
  8. Mar 14, 2025InsiderOfficer sold ~$3.7K of TWST shares in the open market
  9. Mar 20, 2025Insider · 3 peopleInsiders: 3 sales (~$94K)
  10. Apr 2, 2025Insider · 4 peopleInsiders: 4 sales (~$37K)
  11. Apr 9, 2025InsiderCFO sold ~$89K of TWST shares in the open market
  12. Apr 23, 2025InsiderOfficer sold ~$82K of TWST shares in the open market
  13. May 5, 2025Insider · 5 peopleInsiders: 5 sales (~$369K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Twist Bioscience

For Twist Bioscience, OQRO holds 36 insider filings (SEC Form 4 or Form 144), 11 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TWST page.

Other recent filings by Robert Chess, Director

The full history of Robert Chess, Director is on the profile page.

How this filing works

Other disclosures at Twist Bioscience

Everything OQRO holds on this company is on its TWST page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data